Table 3. Effect of cohort and race on pCR after removing tumor type.

Effect	Adjusted Odds Ratio	95% Confidence Interval	P
Cohort:
Bevacizumab	6.03	1.41–25.7	0.015
Standard chemotherapy†	1.00	–––––
Race:
African American	5.96	1.59–22.3	0.0081
European American†	1.00	–––––

† Reference category